Japan Real World Evidence Solutions Market Size & Outlook
Japan real world evidence solutions market, 2018-2030 (US$M)
Related Markets
Japan real world evidence solutions market highlights
- The Japan real world evidence solutions market generated a revenue of USD 87.4 million in 2023 and is expected to reach USD 177.6 million by 2030.
- The Japan market is expected to grow at a CAGR of 10.7% from 2024 to 2030.
- In terms of segment, services was the largest revenue generating component in 2023.
- Services is the most lucrative component segment registering the fastest growth during the forecast period.
Real world evidence solutions market data book summary
| Market revenue in 2023 | USD 87.4 million |
| Market revenue in 2030 | USD 177.6 million |
| Growth rate | 10.7% (CAGR from 2023 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Data Sets |
| Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Other key industry trends
- In terms of revenue, Japan accounted for 3.3% of the global real world evidence solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan real world evidence solutions market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 92.9 million by 2030.
Services was the largest segment with a revenue share of 57.67% in 2023. Horizon Databook has segmented the Japan real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
Countries, such as Japan, are working to fully incorporate RWE, launching the "Rational Medicine" project to make the Japanese healthcare system more patient-centric and evidence-based. In terms of RWE, Japan is in the lead.
According to an article published, Dr. Tatsuya Kondo, the Chief Executive of Japan's Pharmaceuticals and Medical Devices Agency, described the new Rational Medicine initiative, which aims to provide better insight into the risk and benefit balance of drugs, medical devices, & regenerative medical products and create a medical environment where care is strictly evidence-based.
The PMDA plans to use RWD to improve the sophistication of its safety measures to achieve these aims. As a result, these elements aid in strengthening market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Real World Evidence Solutions Market Scope
Real World Evidence Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan real world evidence solutions market size, by component, 2018-2030 (US$M)
Japan Real World Evidence Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
